WELLS FARGO & COMPANY/MN - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is and the CUSIP is 695127AB6. A total of 14 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$55,000
-9.8%
30,0000.0%0.00%
Q3 2018$61,000
+41.9%
30,0000.0%0.00%
Q2 2018$43,000
+2.4%
30,0000.0%0.00%
Q1 2018$42,000
-26.3%
30,0000.0%0.00%
Q4 2017$57,000
+16.3%
30,0000.0%0.00%
Q3 2017$49,000
-18.3%
30,0000.0%0.00%
Q2 2017$60,000
+5.3%
30,0000.0%0.00%
Q1 2017$57,000
+32.6%
30,0000.0%0.00%
Q4 2016$43,000
-4.4%
30,0000.0%0.00%
Q3 2016$45,0000.0%30,0000.0%0.00%
Q2 2016$45,000
-27.4%
30,000
+3.4%
0.00%
Q1 2016$62,000
-8.8%
29,000
+31.8%
0.00%
Q4 2015$68,000
+106.1%
22,000
+10.0%
0.00%
Q3 2015$33,000
-42.1%
20,0000.0%0.00%
Q2 2015$57,000
-60.4%
20,000
-50.0%
0.00%
Q1 2015$144,000
+166.7%
40,000
+166.7%
0.00%
Q4 2014$54,00015,0000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
EQUITEC SPECIALISTS, LLC 3,000,000$4,524,0001.31%
Myriad Asset Management Ltd. 10,000,000$14,880,0000.95%
WHITEBOX ADVISORS LLC 11,350,000$17,117,0000.71%
WOLVERINE ASSET MANAGEMENT LLC 21,743,000$32,797,0000.49%
MIZUHO SECURITIES USA LLC 3,500,000$5,275,0000.44%
Verition Fund Management LLC 1,160,000$1,755,0000.19%
CSS LLC/IL 1,500,000$2,245,0000.11%
PALISADE CAPITAL MANAGEMENT, LP 982,000$1,473,0000.05%
Citadel Advisors 30,050,000$45,358,0000.05%
LAZARD ASSET MANAGEMENT LLC 9,000,000$13,618,0000.03%
View complete list of PACIRA PHARMACEUTICALS INC shareholders